CEO, Psylo
Stories naming Joshua Ismin. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Psylo, a Sydney maker of psychedelic therapies, has landed a US$8 million seed round led by Tenmile while moving to the US; earlier raises in 2022 and 2021 are recalled.
Startup Daily lists the 19 Australian and New Zealand startups in Startmate's largest-ever Winter21 cohort pitching at Demo Day, including a climate stream backed by Mike Cannon-Brookes through Grok Ventures.
Sydney psychedelic biotech Psylo has raised $1.1 million in a round led by Possible Ventures, with angel Daniel Petre also backing it, to develop shorter-acting psilocybin-inspired mental health medicines.